ArticleAmerican journal of infection control2022
A task analysis of central line-associated bloodstream infection (CLABSI) surveillance in home infusion therapy.
Article in American journal of infection control, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 10 citations in OpenAlex.
- Reducing home infusion CLABSI through a dashboard and toolkit implementation.Infection control and hospital epidemiology · 2026Article
- CLABSIs aren't just for inpatients: the need to identify CLABSI burden among outpatients.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2024Article
- Implementing and validating a home-infusion central-line-associated bloodstream infection surveillance definition.Infection control and hospital epidemiology · 2023Article
- The need to expand the infection prevention workforce in home infusion therapy.American journal of infection control · 2023Article
- Controlling the chaos: Information management in home-infusion central-line-associated bloodstream infection (CLABSI) surveillance.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2023Article
- CLABSI Surveillance in Home Infusion: Importance of a Standardized Definition for Improvement.Home healthcare nowArticle
- Implementing a Home Infusion Central Line-Associated Bloodstream Infection Dashboard: Considerations for Dashboard Development.Home healthcare nowArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundBarriers for home infusion therapy central line associated bloodstream infection (CLABSI) surveillance have not been elucidated and are needed to identify how to support home infusion CLABSI surveillance. We aimed to (1) perform a goal-directed task analysis of home infusion CLABSI surveillance, and (2) describe barriers to, facilitators for, and suggested strategies for successful home infusion CLABSI surveillance.
methodsWe conducted semi-structured interviews with team members involved in CLABSI surveillance at 5 large home infusion agencies to explore work systems used by members of the agency for home infusion CLABSI surveillance. We analyzed the transcribed interviews qualitatively for themes.
resultsTwenty-one interviews revealed 8 steps for performing CLABSI surveillance in home infusion therapy. Major barriers identified included the need for training of the surveillance staff, lack of a standardized definition, inadequate information technology support, struggles communicating with hospitals, inadequate time, and insufficient clinician engagement and leadership support. DISCUSSION: Staff performing home infusion CLABSI surveillance need health system resources, particularly leadership and front-line engagement, access to data, information technology support, training, dedicated time, and reports to perform tasks.
conclusionsBuilding home infusion CLABSI surveillance programs will require support from home infusion leadership.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.